{
    "Trade/Device Name(s)": [
        "Cepheid Xpert CT/NG Control Panel"
    ],
    "Submitter Information": "Microbiologics, Inc.",
    "510(k) Number": "K190223",
    "Predicate Device Reference 510(k) Number(s)": [
        "K182472"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PMN"
    ],
    "Summary Letter Date": "February 4, 2019",
    "Summary Letter Received Date": "February 5, 2019",
    "Submission Date": "May 1, 2019",
    "Regulation Number(s)": [
        "21 CFR 866.3920"
    ],
    "Regulation Name(s)": [
        "Assayed quality control material for clinical microbiology assays"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Chlamydia trachomatis",
        "Neisseria gonorrhoeae",
        "Human epithelial cells"
    ],
    "Specimen Type(s)": [
        "Vaginal swab",
        "Endocervical swab"
    ],
    "Specimen Container(s)": [
        "Swab specimen collection kit"
    ],
    "Instrument(s)/Platform(s)": [
        "Cepheid GeneXpert System"
    ],
    "Method(s)/Technology(ies)": [
        "Nucleic acid extraction",
        "Amplification",
        "Detection"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control Panel",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Cepheid Xpert CT/NG Control Panel as an assayed quality control material for qualitative detection of Chlamydia trachomatis and Neisseria gonorrhoeae with GeneXpert CT/NG assay",
    "Indications for Use Summary": "Intended for use as an external assayed positive and negative quality control to monitor performance of in vitro laboratory nucleic acid testing procedures for detection of Chlamydia trachomatis and Neisseria gonorrhoeae with Cepheid Xpert CT/NG assay on GeneXpert System",
    "fda_folder": "Microbiology"
}